ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 128 filers reported holding ANI PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,691,048 | -36.2% | 63,573 | -40.9% | 0.07% | -20.7% |
| Q2 2023 | $5,785,541 | +22.5% | 107,478 | -9.6% | 0.09% | +15.0% |
| Q1 2023 | $4,724,495 | +94408.8% | 118,945 | -4.3% | 0.08% | -1.2% |
| Q4 2022 | $4,999 | -99.9% | 124,270 | -4.2% | 0.08% | +14.1% |
| Q3 2022 | $4,170,000 | +1689.7% | 129,755 | +2172.4% | 0.07% | +1675.0% |
| Q1 2020 | $233,000 | -29.6% | 5,710 | +6.2% | 0.00% | 0.0% |
| Q4 2019 | $331,000 | +4.1% | 5,375 | +23.3% | 0.00% | 0.0% |
| Q3 2019 | $318,000 | -47.6% | 4,359 | -41.0% | 0.00% | -42.9% |
| Q2 2019 | $607,000 | +26.5% | 7,386 | +8.6% | 0.01% | +40.0% |
| Q1 2019 | $480,000 | – | 6,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 326,778 | $20,152,000 | 2.95% |
| Hawk Ridge Capital Management | 188,761 | $11,641,000 | 1.89% |
| Global Alpha Capital Management Ltd. | 169,746 | $10,468,000 | 1.55% |
| Mesirow Financial Investment Management, Inc. | 5,723 | $353,000 | 1.49% |
| 1492 Capital Management LLC | 25,093 | $1,547,000 | 1.37% |
| THB ASSET MANAGEMENT | 91,018 | $5,613,000 | 1.04% |
| Regent Investment Management LLC | 41,329 | $2,549,000 | 0.78% |
| Phocas Financial Corp. | 101,567 | $6,263,000 | 0.75% |
| INVESTMENT COUNSELORS OF MARYLAND LLC | 284,334 | $17,535,000 | 0.75% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 35,500 | $2,189,000 | 0.70% |